Similar articles

• [Personal experience on the chemotherapy of leukemias and hematosarcomas].

  Mathé G, Schneider M, Schwarzenberg L, Cattan A, Amiel JL, Schlumberger JR. Mathé G, et al. Acta Genet Med Gemellol (Roma). 1968 Jan;17(1):245-54. Acta Genet Med Gemellol (Roma). 1968. PMID: 4874537 French. No abstract available.
• Current problems in the use of the oncolytic drugs.

  Armstrong JG. Armstrong JG. Acta Genet Med Gemellol (Roma). 1968 Jan;17(1):270-7. doi: 10.1017/s1120962300026512. Acta Genet Med Gemellol (Roma). 1968. PMID: 4298202 No abstract available.
• Investigations with 1,4-bis-(2'-mesyloxyethylamino)-1,4-dideoxy-meso-erythritol (R-74).

  Hindy I, Sellei C, Eckhardt S, Szentklãray J, Hartai F. Hindy I, et al. Neoplasma. 1971;18(3):277-82. Neoplasma. 1971. PMID: 4937513 No abstract available.
• Antineoplastic and immunosuppressive drugs. II. Therapeutic uses.

  Cridland MD. Cridland MD. Drugs. 1972;3(5):331-51. doi: 10.2165/00003495-197203050-00003. Drugs. 1972. PMID: 4347084 Review. No abstract available.
• The present status of cancer chemotherapy.

  Krakoff IH. Krakoff IH. Med Clin North Am. 1971 May;55(3):683-701. doi: 10.1016/s0025-7125(16)32511-1. Med Clin North Am. 1971. PMID: 4102661 Review. No abstract available.